• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合临床指标可预测纽约心脏协会心功能IV级心力衰竭患者的死亡率。

Combining clinical markers can predict mortality in NYHA IV heart failure.

作者信息

Men Yi-Jiao, Dong Yan-Ling, Gong Yu, An Ya-Qing, Cheng Hong-Bo

机构信息

Department of Emergency, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Department of Neurosurgery, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, China.

出版信息

Sci Rep. 2025 Aug 6;15(1):28721. doi: 10.1038/s41598-025-13274-y.

DOI:10.1038/s41598-025-13274-y
PMID:40770313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12328691/
Abstract

Early assessment of heart failure during treatment can improve patient prognosis. Brain natriuretic peptide (BNP), uric acid (UA), pre-albumin (PA), red blood cell distribution width (RDW), and Cystatin C (Cys C) are related to the development of heart failure. This study determined whether these characteristics could serve as combined diagnostic indicators for the prognosis of New York Heart Association classification (NYHA) IV heart failure (IV-HF). Here, the general clinical and cardiac ultrasound data from 193 patients with NYHA IV-HF were collected and followed-up for six months, and their survival status was recorded. Among the patients, 119 (61.66%) survived, whereas 74 (38.34%) were reported dead at the six-month follow-up. Compared to the survival group, the death group had significantly higher age, disease duration, Cys C, UA, BNP, RDW, left ventricular end-systolic diameter, left ventricular end-diastolic diameter, and left atrial dimension, and lower PA and left ventricular ejection fraction (LVEF). Cys C, UA, BNP, and RDW had significant negative linear correlations with LVEF, while PA had a significant positive linear correlation with LVEF. In addition, high Cys C, UA, BNP, and RDW, as well as low PA, are independent risk factors for mortality in patients with IV-HF. The combination of age, disease duration, RDW, and levels of Cys C, UA, BNP, and PA can serve as diagnostic indicators for mortality in patients with NYHA IV-HF.

摘要

治疗期间对心力衰竭进行早期评估可改善患者预后。脑钠肽(BNP)、尿酸(UA)、前白蛋白(PA)、红细胞分布宽度(RDW)和胱抑素C(Cys C)与心力衰竭的发生发展有关。本研究确定这些特征是否可作为纽约心脏协会心功能分级(NYHA)IV级心力衰竭(IV-HF)预后的联合诊断指标。在此,收集了193例NYHA IV-HF患者的一般临床和心脏超声数据,并进行了为期6个月的随访,记录了他们的生存状态。在这些患者中,119例(61.66%)存活,而74例(38.34%)在6个月随访时报告死亡。与存活组相比,死亡组的年龄、病程、Cys C、UA、BNP、RDW、左心室收缩末期内径、左心室舒张末期内径和左心房内径显著更高,而PA和左心室射血分数(LVEF)更低。Cys C、UA、BNP和RDW与LVEF呈显著负线性相关,而PA与LVEF呈显著正线性相关。此外,高Cys C、UA、BNP和RDW以及低PA是IV-HF患者死亡的独立危险因素。年龄、病程、RDW以及Cys C、UA、BNP和PA水平的组合可作为NYHA IV-HF患者死亡的诊断指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/12328691/ab405d48852b/41598_2025_13274_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/12328691/c2e56ca6ae05/41598_2025_13274_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/12328691/be3bec6bd569/41598_2025_13274_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/12328691/ab405d48852b/41598_2025_13274_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/12328691/c2e56ca6ae05/41598_2025_13274_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/12328691/be3bec6bd569/41598_2025_13274_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/12328691/ab405d48852b/41598_2025_13274_Fig3_HTML.jpg

相似文献

1
Combining clinical markers can predict mortality in NYHA IV heart failure.结合临床指标可预测纽约心脏协会心功能IV级心力衰竭患者的死亡率。
Sci Rep. 2025 Aug 6;15(1):28721. doi: 10.1038/s41598-025-13274-y.
2
Correlation of serum homocysteine and cystatin C levels with prognosis in heart failure with preserved ejection fraction patients.血清同型半胱氨酸和胱抑素 C 水平与射血分数保留的心力衰竭患者预后的相关性。
BMC Cardiovasc Disord. 2024 Sep 27;24(1):510. doi: 10.1186/s12872-024-04058-9.
3
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial.射血分数正常和超常的心力衰竭患者的心肌肌球蛋白抑制作用:EMBARK-HFpEF试验的主要结果
JAMA Cardiol. 2025 Feb 1;10(2):170-175. doi: 10.1001/jamacardio.2024.3810.
4
Does Serum Uric Acid to Creatinine Ratio Predict Mortality Risk in Patients With Heart Failure?血清尿酸与肌酐比值能否预测心力衰竭患者的死亡风险?
Tex Heart Inst J. 2024 May 1;51(1). doi: 10.14503/THIJ-23-8210.
5
Myocardial contrast echocardiography evaluation of coronary microvascular dysfunction to Predict MACEs in patients with heart failure with preserved ejection fraction follow-up.心肌声学造影评估冠状动脉微血管功能障碍预测射血分数保留的心力衰竭患者的主要不良心血管事件的随访。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):496. doi: 10.1186/s12872-024-04173-7.
6
Assessment value of the modified early warning score for long-term prognosis of older patients with chronic heart failure.改良早期预警评分对老年慢性心力衰竭患者长期预后的评估价值
Cardiovasc J Afr. 2024;35(1):40-43. doi: 10.5830/CVJA-2023-003. Epub 2023 Apr 28.
7
Ratio of red blood cell distribution width to albumin: a predictive biomarker of In-hospital mortality in heart failure patients.红细胞分布宽度与白蛋白的比值:心力衰竭患者院内死亡的预测生物标志物。
Acta Cardiol. 2025 Jun;80(4):376-386. doi: 10.1080/00015385.2025.2491151. Epub 2025 Apr 14.
8
Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.B型利钠肽(BNP)和N末端B型利钠肽原(NT-proBNP)检测在心力衰竭诊断和预后评估中的应用
Evid Rep Technol Assess (Full Rep). 2006 Sep(142):1-147.
9
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy-Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer.一种联合超声心动图方法用于诊断早期乳腺癌女性的癌症治疗相关心脏功能障碍。
JAMA Cardiol. 2022 Mar 1;7(3):330-340. doi: 10.1001/jamacardio.2021.5881.
10
Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction: A systematic review and network meta-analysis of randomized clinical trials.联合药物治疗心力衰竭射血分数降低患者的心脏逆重构:随机临床试验的系统评价和网络荟萃分析。
Pharmacol Res. 2021 Jul;169:105573. doi: 10.1016/j.phrs.2021.105573. Epub 2021 Mar 22.

本文引用的文献

1
Human cystatin C in fibrotic diseases.人cystatin C 在纤维化疾病中的作用。
Clin Chim Acta. 2025 Jan 15;565:120016. doi: 10.1016/j.cca.2024.120016. Epub 2024 Oct 24.
2
Psychometric evaluation of the Chinese version of the Chronic Heart Failure Health-related Quality of Life Questionnaire (CHFQOLQ-20).中文版慢性心力衰竭健康相关生活质量问卷(CHFQOLQ-20)的心理测量学评估。
Sci Rep. 2024 Oct 21;14(1):24713. doi: 10.1038/s41598-024-76144-z.
3
Burden and Temporal Trends of Valvular Heart Disease-Related Heart Failure From 1990 to 2019 and Projection Up to 2030 in Group of 20 Countries: An Analysis for the Global Burden of Disease Study 2019.
20 国集团 1990 年至 2019 年期间与瓣膜性心脏病相关的心衰负担和时间趋势,以及对 2030 年的预测:2019 年全球疾病负担研究分析。
J Am Heart Assoc. 2024 Oct 15;13(20):e036462. doi: 10.1161/JAHA.124.036462. Epub 2024 Oct 11.
4
Association between Red Blood Cell Distribution Width and In-Hospital Mortality among Congestive Heart Failure Patients with Diabetes among Patients in the Intensive Care Unit: A Retrospective Cohort Study.重症监护病房中糖尿病性充血性心力衰竭患者红细胞分布宽度与院内死亡率的关联:一项回顾性队列研究
Crit Care Res Pract. 2024 Jul 29;2024:9562200. doi: 10.1155/2024/9562200. eCollection 2024.
5
Assessing red blood cell distribution width in Vietnamese heart failure patients: A cross-sectional study.评估越南心力衰竭患者的红细胞分布宽度:一项横断面研究。
PLoS One. 2024 Jul 23;19(7):e0301319. doi: 10.1371/journal.pone.0301319. eCollection 2024.
6
Red Blood Cell Distribution Width is a Biomarker of Red Cell Dysfunction Associated with High Systemic Inflammation and a Prognostic Marker in Heart Failure and Cardiovascular Disease: A Potential Predictor of Atrial Fibrillation Recurrence.红细胞分布宽度是与全身炎症相关的红细胞功能障碍的生物标志物,也是心力衰竭和心血管疾病的预后标志物:心房颤动复发的潜在预测因子。
High Blood Press Cardiovasc Prev. 2024 Sep;31(5):437-449. doi: 10.1007/s40292-024-00662-0. Epub 2024 Jul 20.
7
Application of neutrophil-lymphocyte ratio and red blood cell distribution width in diabetes mellitus complicated with heart failure.中性粒细胞与淋巴细胞比值及红细胞分布宽度在糖尿病合并心力衰竭中的应用
World J Diabetes. 2024 Jun 15;15(6):1226-1233. doi: 10.4239/wjd.v15.i6.1226.
8
Effect of dapagliflozin on uric acid in patients with chronic heart failure and hyperuricemia.达格列净对慢性心力衰竭合并高尿酸血症患者尿酸的影响。
World J Clin Cases. 2024 Jun 26;12(18):3468-3475. doi: 10.12998/wjcc.v12.i18.3468.
9
Relationship between serum uric acid levels and uric acid lowering therapy with the prognosis of patients with heart failure with preserved ejection fraction: a meta-analysis.血清尿酸水平及降尿酸治疗与射血分数保留的心力衰竭患者预后的关系:一项荟萃分析
Front Cardiovasc Med. 2024 Jun 13;11:1403242. doi: 10.3389/fcvm.2024.1403242. eCollection 2024.
10
Setting the optimal threshold of NT-proBNP and BNP for the diagnosis of heart failure in patients over 75 years.设定 NT-proBNP 和 BNP 对 75 岁以上患者心力衰竭诊断的最佳阈值。
ESC Heart Fail. 2024 Oct;11(5):3232-3241. doi: 10.1002/ehf2.14894. Epub 2024 Jun 24.